Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances

Research output: Contribution to journalJournal articleResearchpeer-review

Meena Asmar, Jens Juul Holst

This article highlights recent advances in our understanding of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) physiology and their various sites of action beyond the incretin effect.
Original languageEnglish
JournalCurrent Opinion in Endocrinology, Diabetes and Obesity
Issue number1
Pages (from-to)57-62
Number of pages6
Publication statusPublished - 1 Feb 2010

    Research areas

  • Adipocytes, Animals, Bone and Bones, Cardiovascular Physiological Processes, Central Nervous System, Gastric Inhibitory Polypeptide, Glucagon-Like Peptide 1, Humans, Insulin-Secreting Cells, Lipid Metabolism, Peripheral Nervous System, Receptors, Gastrointestinal Hormone

ID: 33940651